patented technology to grow and expand adult Stem Cells

Adult stem cell development company commencing clinical trials applicable to estimated $30 billion degenerative disease market place

Free
Message: low of the day 4.50 ..note VOLUME SPIKE AT THIS POINT..heading back
Reply New Message
Prev Message Back To Forum Threaded View Next Message
Pluristem will not automatically be listed on the NASDAQ.  Pluristem must first meet specfic requirement in order to be listed.  I believe one of the requirements is to maintain a share price at or above $5.00 for specified length of time and at the time of the actual listing.  I also think there is a specified amount of income a company must earn in order to be listed.
Reply New Message
Prev Message Back To Forum Threaded View Next Message
Share
Share
New Message
Please login to post a reply